Exosomes are extracellular lipid nanovesicles of 30 nm to 120 nm diameter. These are secreted by different cells and are found in all bodily fluids such as urine, plasma, saliva, serum, and cerebrospinal fluid (CSF). Release of exosomes takes place either upon induction or constitutively, under both pathological and normal conditions, in a regulated, dynamic, and functionally relevant manner. Exosomes are separated from diverse cell lines such as tumor lines, primary cultures, hematopoietic cells, virus infected cells, and also from biological fluids in blood, including plasma and serum from cancer patients and other body fluids such as pleural effusions, broncho alveolar lavage fluid, amniotic fluid, synovial fluid, semen, saliva, and urine. Exosomes have pleiotropic physiological and pathological functions. These play vital role in various pathological conditions such as infectious, cancer, and neurodegenerative diseases.
According to the World Health Organization, globally, cancer is considered to be the second leading cause of death, and it accounted for nearly 9.6 million deaths in 2018. Globally, cancer accounts for around 1 in 6 deaths. The impact of cancer economically is significant and is rising. In 2010, the total annual economic cost of cancer was anticipated at around US$ 1.16 Trn. Rise in prevalence of cancer, increase in funds for life science research, surge in research programs which focus on the determination of the role of exosomes, and increase in interest in exosome-based procedures are the factors boosting the growth of the global exosome research products market. However, shortage of skilled and trained personnel is a major factor likely to hamper the growth of the global exosome research products market during the forecast period.
The global exosome research products market can be segmented based on product & service, application, and end-user. In terms of product & service, the market can be classified into kits & reagents, instruments, and services. The kits & reagents segment is anticipated to account for the largest market share during the forecast period. Based on application, the global exosome research products market can be bifurcated into cancer and non-cancer. The cancer segment can be categorized into colorectal cancer, breast cancer, lung cancer, prostate cancer, and other cancers. The lung cancer sub-segment is projected to account for the largest share of the cancer segment from 2019 to 2027. In terms of end-user, the market can be divided into hospitals & clinical testing laboratories, academic & research institutes, and pharmaceutical & biotechnology companies. The academic & research institutes segment is expected to account for the largest market share during the forecast period.
In terms of region, the global exosome research products market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to dominate the global exosome research products market from 2019 to 2027. This is attributed to favorable regulatory environment, rise in focus and interest in exosome research and diagnostics, and government funding for research on life sciences. Additionally, growth of the pharmaceutical & biotechnology industries and presence of well-built and high-quality infrastructure for laboratory and clinical research drive the market in North America. The market in Asia Pacific is projected to grow at a rapid pace during the forecast period due to rise in research and developmental activities, increase in government initiatives for improving health care, and surge in focus of key players in building or strengthening presence in the region.
Key players in the global exosome research products market include Thermo Fisher Scientific, Bio-Techne, QIAGEN, System Biosciences, LLC, Miltenyi Biotec, NanoSomiX, Norgen Biotek Corp., AMS Biotechnology (Europe) Limited, Lonza, and Novus Biologicals. These players have adopted strategies such as partnerships, agreements, new product development, and collaborations to gain competitive advantage in the global exosome research products market.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.